EMPHYSEMA
Clinical trials for EMPHYSEMA explained in plain language.
Never miss a new study
Get alerted when new EMPHYSEMA trials appear
Sign up with your email to follow new studies for EMPHYSEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could boost success of lung valves for emphysema patients
Disease control Not yet recruitingThis study tests whether a new scan method (VQDI) helps doctors pick the best lung area for placing tiny valves in people with severe emphysema. About 285 participants will be randomly assigned to either the new scan method or the standard CT-based method. The goal is to see if t…
Matched conditions: EMPHYSEMA
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
Can a higher dose of an existing drug preserve lung function in Alpha-1 patients?
Disease control Not yet recruitingThis study tests whether higher doses of the drug Respreeza/Zemaira, given as weekly IV infusions over 3 years, can slow the loss of lung density in adults with emphysema caused by Alpha-1 antitrypsin deficiency. About 270 participants aged 18-65 with a confirmed genetic form of …
Matched conditions: EMPHYSEMA
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated May 14, 2026 12:05 UTC